As an analyst tracking small-cap biotech names, Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) has always been one of my favorites, thanks to the company’s evolution from a TAVALISSE-centric company ...

Rigel Pharmaceuticals Inc. (RIGL) reported robust financial results for Q1 2025, with total revenue reaching $53.3 million, marking a 68% year-over-year increase. The company’s net income was $ ...

Laser-cooled atomic gases, gases of atoms chilled to temperatures around absolute zero using laser technologies, have proved to be versatile physical platforms to study and control quantum phenomena.

NEW Delhi: India for the first time on Sunday demonstrated the capability to use a potent 30-kilowatt laser-based system to disable, degrade or destroy small remotely-piloted aircraft, swarm ...

Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) shareholders are probably feeling a little disappointed, since its shares fell 9.6% to US$19.70 in the week after its latest annual results. It looks like a ...

Transcelestial's Laser Comms To Aid Non-Terrestrial Network Research is published in Aerospace Daily & Defense Report, an Aviation Week Intelligence Network (AWIN) Market Briefing and is included ...

LAMAR COUNTY, Miss. (WDAM) - Lamar County Sheriff Danny Rigel has documented 40 years of his law enforcement career in a binder. Most officers would use crime reports or newspaper clippings Rigel ...

SOUTH SAN FRANCISCO, Calif., Jan. 13, 2025 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), a commercial stage biotechnology company focused on hematologic disorders and cancer, today ...

Rigel Pharmaceuticals' strategic acquisitions of GAVRETO and REZLIDHIA, along with strong TAVALISSE sales, position the company for significant growth and potential profitability. Despite ...